The TNFAIP2 Polyclonal Antibody (PACO55806) is a valuable tool for research involving TNFAIP2, a protein known to play a role in immune regulation and inflammation. This antibody, produced in rabbits, is highly specific for human samples and has been validated for use in Western blot applications. By binding to the TNFAIP2 protein, this antibody allows for the detection and analysis of TNFAIP2 expression in various cell types, making it an essential tool for studies in immunology and cancer research.TNFAIP2, also known as TNF alpha-induced protein 2, is involved in regulating immune responses and inflammation, making it a key player in diseases such as cancer, autoimmune disorders, and chronic inflammatory conditions.
Understanding the function of TNFAIP2 is crucial for developing targeted therapies that can modulate immune responses in these contexts. The TNFAIP2 Polyclonal Antibody provides researchers with the ability to study TNFAIP2 expression and activity, advancing our understanding of its role in health and disease.
Antibody Name:
TNFAIP2 Antibody (PACO55806)
Antibody SKU:
PACO55806
Size:
50ug
Host Species:
Rabbit
Tested Applications:
ELISA, WB
Recommended Dilutions:
ELISA:1:2000-1:10000, WB:1:500-1:5000
Species Reactivity:
Human, Mouse
Immunogen:
Recombinant Human Tumor necrosis factor alpha-induced protein 2 protein (1-93AA)
Western Blot. Positive WB detected in: Mouse liver tissue. All lanes: TNFAIP2 antibody at 6.9µg/ml. Secondary. Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 73 kDa. Observed band size: 73 kDa.
Background:
May play a role as a mediator of inflammation and angiogenesis.
Synonyms:
Tumor necrosis factor alpha-induced protein 2 (TNF alpha-induced protein 2) (Primary response gene B94 protein), TNFAIP2
UniProt Protein Function:
TNFAIP2: May play a role as a mediator of inflammation and angiogenesis. Belongs to the SEC6 family.
This gene was identified as a gene whose expression can be induced by the tumor necrosis factor alpha (TNF) in umbilical vein endothelial cells. The expression of this gene was shown to be induced by retinoic acid in a cell line expressing a oncogenic version of the retinoic acid receptor alpha fusion protein, which suggested that this gene may be a retinoic acid target gene in acute promyelocytic leukemia. [provided by RefSeq, Jul 2008]
